NCT02763007 - An Extension Study of PEAK Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 18, 2016

Primary Completion Date

December 19, 2018

Study Completion Date

February 28, 2019

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

alogliptin+pioglitazone

alogliptin and pioglitazone add on metformin

DRUG

alogliptin

nesina add on metformin

DRUG

pioglitazone

actos add on metformin

Trial Locations (1)

Seoul St Mary's Hospital, The Catholic University of Korea, Seoul